1. Home
  2. ATGL vs TARA Comparison

ATGL vs TARA Comparison

Compare ATGL & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Technology Group Limited

ATGL

Alpha Technology Group Limited

BUY

Current Price

$12.30

Market Cap

241.3M

Sector

N/A

ML Signal

BUY

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$4.02

Market Cap

269.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATGL
TARA
Founded
2017
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.3M
269.8M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
ATGL
TARA
Price
$12.30
$4.02
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$24.40
AVG Volume (30 Days)
2.3K
669.9K
Earning Date
01-27-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.25
EPS
N/A
N/A
Revenue
N/A
$2,948,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.01
$2.77
52 Week High
$50.00
$7.82

Technical Indicators

Market Signals
Indicator
ATGL
TARA
Relative Strength Index (RSI) 41.79 40.08
Support Level $9.75 $3.62
Resistance Level $20.25 $5.53
Average True Range (ATR) 1.31 0.24
MACD 0.04 0.00
Stochastic Oscillator 31.12 34.60

Price Performance

Historical Comparison
ATGL
TARA

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: